Study objective: To determine whether the excreted metabolities of nal
oxone hydrochloride cause positive urine toxicologic screens for opiat
es. Design: Prospective, randomized, double-blinded human protocol. Se
tting: Urban Level I military emergency department. Participants: Four
teen adult volunteers who took no routine medications, were not pregna
nt, had no known sensitivity to naloxone, and who were negative for a
pretest urine and serum toxicologic screen. Interventions: We administ
ered either 2 or 4 mg IV naloxone to 14 subjects. Urine drug screening
was obtained before administration and at 60 minutes, 6 hours, and 48
hours after administration. Results: All urine drug screens using the
enzyme-multiplied immunoassay technique were negative for opiates at
both dosage levels. The sample size of 14 yielded a power of more than
.99 to detect the difference between positive and negative samples. C
onclusion: Although the metabolities of naloxone hydrochloride are sim
ilar in structure to oxymorphone and are excreted in human urine for s
everal days, naloxone was not associated with a positive enzymatic uri
ne screen for opiates.